Free tool
FAERS Monitor: Imitrex Statdose (Autoinjector)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020080 or its brand name (Imitrex Statdose (Autoinjector), Sumatriptan Succinate). Reports on generic versions are filed under their own applications.
Reports
38,243
Serious
19,164
50% of reports
Hospitalization
7,193
Death reported
909
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5,506
- headache3,209
- nausea2,893
- migraine2,820
- fatigue2,169
- pain2,016
- dizziness1,727
- vomiting1,649
- dyspnoea1,384
- off label use1,332
- anxiety1,310
- diarrhoea1,242
- arthralgia1,085
- malaise1,080
- depression1,058
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 893 |
| 2005 | 1,256 |
| 2006 | 842 |
| 2007 | 851 |
| 2008 | 792 |
| 2009 | 865 |
| 2010 | 798 |
| 2011 | 904 |
| 2012 | 1,153 |
| 2013 | 1,087 |
| 2014 | 1,410 |
| 2015 | 2,197 |
| 2016 | 2,977 |
| 2017 | 2,171 |
| 2018 | 2,645 |
| 2019 | 3,028 |
| 2020 | 2,670 |
| 2021 | 2,165 |
| 2022 | 2,176 |
| 2023 | 2,174 |
| 2024 | 1,888 |
| 2025 | 1,858 |
| 2026 | 1,440 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,015,916 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| migraineSignal | 2,820 | 16.7 | 16.1 | 40,592 |
| headacheSignal | 3,209 | 2.8 | 2.7 | 3,876 |
| depressionSignal | 1,058 | 2.6 | 2.4 | 1,015 |
| anxietySignal | 1,310 | 2.5 | 2.4 | 1,231 |
| drug ineffectiveSignal | 5,506 | 2.3 | 2.2 | 4,312 |
| nauseaSignal | 2,893 | 2.0 | 1.9 | 1,528 |
| vomiting | 1,649 | 1.9 | 1.8 | 755 |
| dizziness | 1,727 | 1.9 | 1.8 | 760 |
| pain | 2,016 | 1.8 | 1.7 | 746 |
| fatigue | 2,169 | 1.5 | 1.5 | 417 |
| arthralgia | 1,085 | 1.4 | 1.4 | 146 |
| malaise | 1,080 | 1.4 | 1.3 | 102 |
| dyspnoea | 1,384 | 1.3 | 1.3 | 125 |
| diarrhoea | 1,242 | 1.1 | 1.0 | 4 |
| off label use | 1,332 | 0.8 | 0.8 | 44 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.